Clinical Trials on Adult With Solid Cancer

Total 3249 results

NCIC Clinical Trials Group

Completed

MG98 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States, Canada
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Endostatin in Treating Patients With Advanced Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Genzyme, a Sanofi Company

Completed

SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Genzyme, a Sanofi Company

Completed

Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada, United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
MedImmune LLC

Completed

Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vanderbilt University
National Cancer Institute (NCI)

Terminated

Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Kaiser Permanente
National Cancer Institute (NCI)

Completed

Individual Counseling and/or Computer-Based Counseling in Helping Healthy Women Adopt a Cancer Prevention Diet

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Centre, Singapore

Completed

Irinotecan in Treating Asian Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Singapore
Mayo Clinic
National Cancer Institute (NCI)

Completed

Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery

Unspecified Adult Solid Tumor, Protocol Specific

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Irinotecan in Treating Aging Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Pittsburgh
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers

Unspecified Adult Solid Tumor, Protocol Specific

United States
Herbert Hurwitz, MD
National Cancer Institute (NCI)

Completed

Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute

Withdrawn

Icotinib Hydrochloride in Treating Patients With Advanced Cancers

Unspecified Adult Solid Tumor, Protocol Specific
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Yale University
National Cancer Institute (NCI)

Terminated

High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies

Unspecified Adult Solid Tumor, Protocol Specific

Canada
National Cancer Institute (NCI)

Completed

Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Pittsburgh
National Cancer Institute (NCI)

Withdrawn

Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
Children's Hospital Medical Center, Cincinnati
National Cancer Institute (NCI)

Unknown

Dietary Soy Isoflavones for the Prevention of Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery

Unspecified Adult Solid Tumor, Protocol Specific

United States
Virginia Polytechnic Institute and State University
National Cancer Institute (NCI)

Completed

An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physical Activity and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

3-AP in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Cancer Research UK

Completed

Geldanamycin Analogue in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

T138067 Sodium in Treating Patients With Advanced Refractory Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Polyglutamate Camptothecin in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Combination Chemotherapy In Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Sirius Medicine

Completed

Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Jewish General Hospital
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
National Cancer Institute (NCI)

Completed

17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants (IRB 2004-535)

Unspecified Adult Solid Tumor, Protocol Specific

United States, United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Etoposide and Celecoxib in Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

BMS-599626 in Treating Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Astex Pharmaceuticals, Inc.

Completed

Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

Unspecified Adult Solid Tumor, Protocol Specific

United States
European Organisation for Research and Treatment...

Completed

Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care

Unspecified Adult Solid Tumor, Protocol Specific

France, United Kingdom, Belgium, Spain, Sweden
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Study of Hair Samples From Patients With Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Georgetown University
National Cancer Institute (NCI)

Completed

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

SU5416 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

SU5416 and Paclitaxel in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

BMS-214662 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Unknown

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

Unspecified Adult Solid Tumor, Protocol Specific
Centre Leon Berard
Bayer

Active, not recruiting

A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib (LAROTRACKING)

Metastatic Cancer | Solid Tumor, Adult | Locally Advanced Solid Tumor

France
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions
National Cancer Institute (NCI)

Completed

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions

United States

Clinical Trials on Adult With Solid Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations